Interestingly, enhanced SREBP2 activity, indicative for elevated cellular cholesterol synthesis and biosynthetic flux, was found to correlate with disease severity in COVID-19 patients, and further directly associated with the development of a systemic cytokine storm (Lee et al., 2020). The gene discussed is SREBF2; the disease is COVID-19.